WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ROIVANT wurde als Wortmarke am 11.12.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1477877 |
| Registernummer | 725025 |
| Länder | 
|
| Basismarke |
Nr. 725025,
03. August 2018
|
| Anmeldedatum | 11. Dezember 2018 |
| Ablaufdatum | 11. Dezember 2028 |
Markeninhaber
Viaduktstrasse 8
4051 Basel
CH
4051 Basel
CH
Markenvertreter
151 West 42nd Street, 17th Floor
New York NY 10036
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for human use; biologic
preparations for medical and therapeutic purposes
09
Calculating machines, data processing equipment, computer
equipment; computer software; computer software for
providing, analyzing and generating reports; computer
software for data processing; electronic apparatus,
electronic equipment, software, programs and systems for the
capture, collection, conversion, analysis, communication,
processing, receiving, recording, storage and transmission
of data, images and information; electronic apparatus,
electronic equipment, software, programs and systems for the
conversion, analysis, processing, storage and transmission
of artificial intelligence; computer software for database
integration; computer software for creating searchable
databases of information and data; software for analysis in
the fields of public health, healthcare, pharmaceutical and
biomedical research and software for analysis of data from
clinical trials as well as post-authorization research for
the marketing of medicines and/or commercial post-launching
of medicines; downloadable computer software featuring
computer databases of pharmaceuticals and medical
information; downloadable computer software for management
of medical practices and research; downloadable computer
search engine software for obtaining and providing updated
scientific, medicinal, pharmaceutical and clinical
information, and for obtaining and providing news of general
interest; computer software for accessing data and
information related to healthcare services and patient
medical information and for controlling and managing data
and information related to healthcare services and patient
medical information; downloadable computer software for
measuring, monitoring, processing and tracking health,
wellness and medical information; computer hardware and
software for use with medicinal patient monitoring equipment
and for receiving, processing, transmitting and displaying
data
35
Advertising; business management; business administration;
secretarial services; business research and information
services; market research and provision of information
regarding market research; data processing services;
analysis of business data; analysis, documentation and
professional business consultancy services regarding
statistics for biomedical research, healthcare institutions
and healthcare professionals, based on artificial
intelligence and machine learning; business analysis and
statistical analysis relating to healthcare data, biomedical
and pharmaceutical research and clinical trial data as well
as data from post-authorization research for marketing of
medicines and/or commercial post-launching of medicines;
systematization and compilation of data in computer
databases; compilation of data, analysis of business data
and business management analysis in the field of
pharmaceutical and biomedical research and development,
clinical trials, post-authorization research for the
marketing of medicines and/or commercial post-launching of
medicines, epidemiological research,
pharmaco-epidemiological research, public health and
healthcare; compilation of data, analysis of business data
and business management analysis for medical, public health
and healthcare purposes; business research, business market
prospecting and statistical analysis in the fields of public
health, health care, biomedicine and pharmaceuticals, as
well as clinical trials and post-authorization research for
the marketing of medicines and/or commercial post-launching
of medicines; providing information regarding market
intelligence services and competitive intelligence services
in the fields of pharmaceuticals, biomedicine, clinical
trials, post-authorization research for the marketing of
medicines and/or commercial post-launching of medicines,
epidemiological research, pharmaco-epidemiological research,
public health and healthcare; business advisory services,
consultancy and information; business risk management and
business risk assessment services; providing reimbursement
comparative evaluation information and other market
intelligence to healthcare organizations; collecting
insurance claims data and business analysis of insurance
claims data from health and health care organizations for
commercial purposes; business services provided to the
healthcare industry, namely, the collection, reporting, and
analysis of healthcare data for business purposes
36
Financial analysis; financial consulting; financial
valuations and forecasting; financial analysis, namely,
compiling and analyzing statistics and data; financial
analysis of investments in pharmaceutical and biomedical
research and development and clinical trials and
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines; providing
financial services with respect to securities and other
financial instruments and products, namely, trading of and
investments in securities and financial instruments and
products for others; financial evaluation, tracking,
analysis, forecasting, consultancy, advisory and research
services relating to securities and other financial
instruments; financial research related to financial
instruments
41
Teaching; training; educational information in the field
of healthcare and pharmaceuticals; arranging, conducting and
organization of conferences, workshops, seminars, and
symposiums to promote the exchange of information and
resources within the scientific research and medical
communities to achieve advances in the fields of healthcare
and pharmaceuticals
42
Scientific and technological services and research and
design relating thereto; analysis of technical data by
computers; pharmaceutical, biomedical, biological
therapeutic research services; research in the field of
pharmaceutical and biologic therapeutic products;
pharmaceutical research and development; providing
scientific research information in the field of
pharmaceuticals, biomedicine, clinical trials and
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines; cloud
computing; providing temporary use of online
non-downloadable computer software containing databases of
pharmaceutical products, medical information, clinical trial
data as well as data from post-authorization research for
the marketing of medicines and/or commercial post-launching
of medicines; providing temporary use of online
non-downloadable computer software for management of medical
practices and research; providing temporary use of online
non-downloadable computer search engine software for
obtaining and providing updated scientific, medical and
clinical information, and for obtaining and providing news
of general interest; providing temporary use of online
non-downloadable computer software for accessing data and
information related to healthcare services and patient
medicinal information and for controlling and managing data
and information related to healthcare services and patient
medicinal information; providing temporary use of
non-downloadable software applications accessible via a web
site for data analytics, financial analytics and risk
management for use in the fields of pharmaceutical and
biomedical research and development, clinical trials, and
the provision of medical and healthcare services
44
Providing health and medical information; providing
Internet-based healthcare information; providing medical
information to healthcare professionals regarding patient
data; providing information relating to the diagnostic,
prophylactic and therapeutic properties of pharmaceutical
and biological products for the prevention and treatment of
diseases, disorders and conditions; medical services;
medical and pharmaceutical consultation; medical services,
namely, providing medical services and consultation over the
telephone and via the Internet through the use of personal
computers, smartphones, tablets, mobile and wireless
devices, and other telecommunication devices; medical
assistance in the nature of the provision of medical
information for medical professionals from remote locations
via the Internet and global computer networks through the
use of a data storage and retrieval system
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 08. August 2022 | 2022/40 Gaz | PH | RAW: Total Invalidation |
| 12. August 2021 | 2021/33 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 17. Februar 2021 | 2021/7 Gaz | MX | Ablehnung |
| 11. Januar 2021 | 2021/2 Gaz | TR | Ablehnung |
| 29. Dezember 2020 | 2021/1 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Dezember 2020 | 2020/51 Gaz | TH | Ablehnung |
| 03. November 2020 | 2020/45 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. Oktober 2020 | 2020/46 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Oktober 2020 | 2020/43 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 10. September 2020 | 2020/37 Gaz | JP | Ablehnung |
| 14. Juli 2020 | 2020/29 Gaz | VN | Ablehnung |
| 06. Juli 2020 | 2020/28 Gaz | UA | Ablehnung |
| 12. Juni 2020 | 2020/25 Gaz | NO | Ablehnung |
| 02. Juni 2020 | 2020/23 Gaz | CO | Ablehnung |
| 19. Mai 2020 | 2020/21 Gaz | ID | Ablehnung |
| 21. April 2020 | 2020/17 Gaz | KR | Ablehnung |
| 09. April 2020 | 2020/22 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. März 2020 | 2020/10 Gaz | RS | Ablehnung |
| 08. Februar 2020 | 2020/8 Gaz | PH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Januar 2020 | 2020/5 Gaz | RU | Ablehnung |
| 15. Januar 2020 | 2020/4 Gaz | IL | Ablehnung |
| 14. Januar 2020 | 2020/3 Gaz | AU | Ablehnung |
| 20. Dezember 2019 | 2019/52 Gaz | EM | Ablehnung |
| 09. Oktober 2019 | 2019/41 Gaz | GB | Ablehnung |
| 01. Oktober 2019 | 2019/41 Gaz | IN | Ablehnung |
| 13. September 2019 | 2019/38 Gaz | SG | Ablehnung |
| 08. August 2019 | 2019/33 Gaz | PH | Ablehnung |
| 06. August 2019 | 2019/33 Gaz | NZ | Ablehnung |
| 11. Dezember 2018 | CH | Eintragung |
ID: 141477877